Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6706 to 6720 of 7707 results

  1. Bavituximab for treating non-squamous non-small-cell lung cancer after platinum-based chemotherapy [ID975]

    Discontinued [GID-TA11260]

  2. Ataluren for treating cystic fibrosis in people with a CFTR gene nonsense mutation [ID955]

    Discontinued [GID-TA11262]

  3. ADI-PEG 20 for previously treated hepatocellular carcinoma [ID1025]

    Discontinued [GID-TA10259]

  4. Nilotinib for the first line treatment of chronic myeloid leukaemia [ID79]

    Discontinued [GID-TAG408]

  5. Psoriatic arthritis (moderate to severe) - leflunomide [ID391]

    Discontinued [GID-TAG385]

  6. Histamine dihydrochloride with interleukin-2 for maintenance treatment of acute myeloid leukaemia [ID1627]

    In development [GID-TA10575] Expected publication date: TBC

  7. Cardiovascular events (prevention, high risk) - anacetrapib [ID1164]

    Discontinued [GID-TA11176]

  8. Osteoarthritis - diacerein [ID332]

    Discontinued [GID-TAG250]

  9. Nivolumab monotherapy for non-small-cell lung cancer [ID1088]

    Discontinued [GID-TA10148]

  10. Multiple sclerosis (primary-progressive) - fingolimod [ID62]

    Discontinued [GID-TAG221]

  11. Human Growth Hormone for Idiopathic Short Stature (in children)[ID317]

    Discontinued [GID-TA11256]

  12. Venous thromboembolism (recurrent) - idraparinux sodium [ID395]

    Discontinued [GID-TAG384]

  13. Sacubitril valsartan for treating chronic heart failure with preserved ejection fraction [ID1606]

    Discontinued [GID-TA11257]

  14. Heart failure (acute decompensated) - nesiritide [ID384]

    Discontinued [GID-TAG376]

  15. Ibrutinib with corticosteroids for untreated chronic graft versus host disease [ID3792]

    Discontinued [GID-TA10722]